Dergiler / Turkish Thoracic Journal / 2021 / Cilt: 22 - Sayı: 3

Providing Free Access to Smoking Cessation Medications: Does It Have an Impact on the Treatment Adherence and Success of Smoking Cessation?

Sayfa
224–230
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

At the end of 3 months, the success of quitting smoking was 14.1 times higher for those who were fully adherent to treatment than non-adherents.DISCUSSION: According to our study results, the most effective success factors in short-term smoking cessation are patient complianceto treatment and free supply of stop-smoking medications, one of the main determinants of treatment adherence.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Providing medications to patients free of charge is thought to be one of the factors affecting the success of smoking cessation.
📊
Temel Bulgular & Veri:The aim of this study was to investigate the effect of providing free access to stop-smoking medications on the treatment adherenceand short term success of quitting smoking.MATERIAL AND METHODS: All smokers who applied to a smoking cessation outpatient clinic between September 2017 and December2019 were included in this retrospective study.
💡
Sonuç & Katkı:At the end of 3 months, the success of quitting smoking was 14.1 times higher for those who were fully adherent to treatment than non-adherents.DISCUSSION: According to our study results, the most effective success factors in short-term smoking cessation are patient complianceto treatment and free supply of stop-smoking medications, one of the main determinants of treatment adherence.
🔬Tür:Araştırma Makalesi
📍Kapsam:2017 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Providing medications to patients free of charge is thought to be one of the factors affecting the success of smoking cessation. The aim of this study was to investigate the effect of providing free access to stop-smoking medications on the treatment adherenceand short term success of quitting smoking.MATERIAL AND METHODS: All smokers who applied to a smoking cessation outpatient clinic between September 2017 and December2019 were included in this retrospective study. Data were collected from patients’ files filled using an initial evaluation and follow-upprotocol.RESULTS: During the study period, 518 smokers applied to our polyclinic for smoking cessation counseling. Medical therapy was prescribed for 411 (85.4%) of 481 patients who were supported by behavioral therapy. The patients had a mean age of 41.2 years, and64.7% were male. Only 22.9% of smokers prescribed stop-smoking medications were able to obtain them for free. Patients who got themedications completely free of charge were 4 times more adherent to treatment. The success rate of quitting smoking at the end of thethird month was 22.2%. The strongest effect was achieved by the full treatment compliance. At the end of 3 months, the success of quitting smoking was 14.1 times higher for those who were fully adherent to treatment than non-adherents.DISCUSSION: According to our study results, the most effective success factors in short-term smoking cessation are patient complianceto treatment and free supply of stop-smoking medications, one of the main determinants of treatment adherence.

🔖

Bu Makaleye Atıf Yap

AKSEL, O., KUCUKTEPE, N., YASLICA, Z., BAŞAK, O. (2021). Providing Free Access to Smoking Cessation Medications: Does It Have an Impact on the Treatment Adherence and Success of Smoking Cessation?. Turkish Thoracic Journal, Cilt: 22 - Sayı: 3, 224–230. https://ajindex.com/articles/414139

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (9)

  1. World Health Organization. Report on the global tobacco epidemic. Monitoring Tobacco Use and Prevention Policies. 2017
  2. Tütün Kontrolü, Strateji Belgesi, ve Eylem Planı.; 2018-2023
  3. Küresel yetişkin tütün araştırması. 2008. Türkiye İstatistik Kurumu. Available: www.tuik.gov.tr/IcerikGetir.do?istab_id=215 4. Yasar Z, Kar Kurt O, Talay F, Kargi A. One-year follow-up results of smoking cessation outpatient clinic: factors affecting the cessation of smoking. Eurasian J Pulmonol. 2014;16:99-104. [CrossRef] 5. Jorenby DE, Hays JT, Rigotti NA et al. Efficacy of varenicline, an alpha4beta2nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA. 2006;296:56- 63. [CrossRef] 6. Fidan F, Pala E. Sigara bırakmayı etkileyen faktörler ve uygulanan tedavlerin başarı oranları. Kocatepe Tıp Derg. 2005;6:27-34
  4. Global adult tobacco survey - fact sheet - Turkey 2017 [internet]. Data SurveyResources/Ancillary/DownloadAttachment.aspx? ID=3452.
  5. Gücük S, Kayhan M, Sıklıkları İle HKG., İlişkisi SBD. Polikliniğimizin ilk bir yillik sonuçlari. Osmangazi Tıp Derg. 2019;41:371-379. [CrossRef] 9. Kanatsız B. Sigara bırakma başarısını etkileyen faktörler ve medikal tedavilerin değerlendirilmesi. Eurasian J Fam Med. 2017;6:65-71
  6. World Health Organization. Report on the global tobacco epidemic.MPOWER. Warning about the Dangers of Tobacco. 2011:49
  7. Berkeşoğlu Ç, Özgür ES, Demir AU. Sigara bırakma başarısını etkileyen faktörler. Mersin Univ Saglık Bilim Derg. 2018;11:355- 365. [CrossRef] 12. Yılmaz A, Turan A. Sigara bırakma tedavisindeki hastalarımızın genel özellikleri ve tedavi başarısını etkileyen faktörler. İzmir Göğüs Hastanesi. 2015:145-149
  8. Aksel O., Basak O. Basic behavioural characteristics of tobacco use in patients who plan quitting. TJFMPC. 2019;13:542-547
  9. Karadoğan D., Önal Ö., Kanbay Y. How does reimbursement status affect smoking cessation interventions? a real-life experience from the eastern Black Sea region of Turkey. Tob Induc Dis. 2019;17:05. [CrossRef] 15. Trapero-Bertran M., Muñoz C, Coyle K et al. Cost-effectiveness of alternative smoking cessation scenarios in spain: results from the EQUİPTMOD. Addiction. 2018;113:65-75. [CrossRef] 16. Cadier B., Durand-Zaleski I, Thomas D, Chevreul K. Cost effectiveness of free access to smoking cessation treatment in france considering the economic burden of smoking–related dise